A prospective study of the pattern of non-antimicrobial drug use in neonatal intensive care management in a tertiary care hospital

Anitha P.; Pundarikaksha H. P.; Yashoda H. T.

doi:10.18203/2319-2003.ijbcp20162438

Authors

Anitha P. Department of Pharmacology, Sri Siddhartha Medical College, Tumkur, Karnataka, India
Pundarikaksha H. P. Department of Pharmacology,Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India
Yashoda H. T. Department of Pediatrics, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20162438

Keywords:

NICU, NICM, RDS

Abstract

Background: Neonatal intensive care management (NICM) may be required for high risk or critically ill neonates for survival or stabilization. NICM involves the use of different classes of drugs, and the pattern of use mainly determined by the prevailing clinical conditions and complications, and the desired therapeutic objectives. The objective of this study was to study the pattern of drug use in NICM, criteria for drug selection and dose individualization, to assess the efficacy and safety of medications and record drug interactions.

Methods: The pattern of drug use was assessed prospectively in 150 consecutive subjects admitted to NICU. The number of drugs used, therapeutic class, dose, route, frequency and duration of administration, criteria for selection were recorded. The efficacy and safety of the medications was assessed by the treatment outcome and by observing for any adverse events or drug interactions.

Results: Different therapeutic classes of drugs were used as per the prevailing clinical conditions or complications. The total number of drugs used was 23. Different classes of drugs were used for specific indications. The treatment outcome was very good in most of the subjects and no drug related adverse events or interactions were observed.

Conclusions: Most of the problems and complications in high risk and critically ill neonates can be prevented or controlled by judicious use of several classes of drugs, properly chosen and individualised to the given situation, without producing serious adverse events and interactions. Drugs play an important role in improving the outcome.

Metrics

Metrics Loading ...

References

Uppal R, Chhabra A, Narang A. Pattern of drug use in neonatal intensive care unit. Indian Pediatrics. 1998;35:647-9.

Kumar M, Thakur S, Singh B. Study of the morbidity and the mortality patterns in the neonatal intensive care unit at a tertiary care teaching hospital in Rohtas District, Bihar, India. Journal of Clinical and Diagnostic Research. 2012;6(2):282-5.

Narayan R. A study of the pattern of admissions and outcome in a neonatal intensive care unit at high altitude. Sri Lanka Journal of Child Health. 2012;41(2):79-81.

Rahim F, Jan A, Mohummad J, Iqbal H. Pattern and outcome of admissions to neonatal unit of Khyber teaching hospital, Peshawar. Pak j med sci. 2007;23(2):249-53.

Neonatal intensive care unit. Available at http://en.wikipedia.org/wiki/Neonatal_intensive_care_unit. Accessed on 13 May 2013.

Kumar P, Walker JK, Hurt KM, Bennett KM, Grosshans N, Fotis MA. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. J Pediatr. 2008;152:412-5.

Warrier I, Du W, Natarajan G, Salari V, Aranda J. Patterns of drug utilisation in a neonatal intensive care unit. J Clin Pharmacol. 2006;46:449-55.

Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117:1979-87.

Koren G. Special aspects of perinatal and pediatric pharmacology. In: Katzung BG, Masters SB, Trevor AG, editors. Basic and Clinical Pharmacology. 12th ed, New Delhi: Mc Graw Hill; 2012:1039-1050.

Walson PD. Pediatric clinical pharmacology and therapeutics. In: Speight TM, Holford NHG, editors. Avery’s drug treatment 4th ed, Adis press; 1997:127-171.

Kamath BD, Todd JK, Glazner JE, Lezotte, Lynch AM. Neonatal Outcomes after Elective Caesarean Delivery. Obstet Gynecol. 2009;113:1231-8.

Jongh BE, Locke R, Paul DA, Hoffman M. The differential effects of maternal age, race/ethnicity and insurance on neonatal intensive care unit admission rates. BMC Pregnancy and Childbirth. 2012;12:97.

Lisonkova S, Janssen PA, Sheps SB, Lee SK, Dahlgren L. The effect of maternal age on adverse birth outcomes: Does parity matter? J Obstet Gynecol Can. 2010;32(6):541-8.

Pepler PT, Uys DW, Nel DG. Predicting mortality and length of stay for neonatal admissions to private hospital neonatal intensive care units: a Southern African retrospective study. African Health Sciences. 2012;12(2):166-73.

Noori S, Seri I. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents. Clin Perinatol. 2012;39:221-38.

Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral Sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Paediatrics. 2006;117(4):1077-83.

Hall RW, Shbarou RM. Drug of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol. 2009;36:215-26.

McDonald CL, Ainsworth SB. An update on the use of surfactant in neonates. Current Paediatrics. 2004;14:284-9

Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W. Drug utilization on a preterm and neonatal intensive care unit in Germany: a prospective, cohort based analysis. Eur J Clin Pharmacol. 2010;66:87-95.

Malcolm WF, Cotton M. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Clin Perinatol. 2012;39:99-109.

Rao ND, Bavdekar SB, Raghunandana KG, Joshi SY, Hathi GS. Calcium supplement for preterm and low birth weight neonate. Indian Pediatrics. 1994;31:657-60.